Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality

被引:28
作者
Versmissen, Jorie [1 ]
Botden, Ilse P. G. [1 ]
Huijgen, Roeland [2 ]
Oosterveer, Daniella M. [1 ]
Defesche, Joep C. [2 ]
Heil, Thea C. [1 ]
Muntz, Anouk [1 ]
Langendonk, Janneke G. [1 ]
Schinkel, Arend F. L. [1 ]
Kastelein, John J. P. [2 ]
Sijbrands, Eric J. G. [1 ]
机构
[1] Erasmus Univ, Dept Internal Med, Med Ctr, Rotterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Familial hypercholesterolemia; Pregnancy; Coronary heart disease; Risk factors; GENE-MUTATIONS; PREGNANCY; RISK; EXPOSURE; CHILDREN; LDL; ATHEROSCLEROSIS; MOTHERS; LIPIDS; WOMEN;
D O I
10.1016/j.atherosclerosis.2011.08.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Fetal exposure to maternal hypercholesterolemia increases the extent of fatty-streak formation in fetal aortas as well as the rate of progression, and may therefore increase coronary heart disease (CHD) risk later in life. We hypothesized that the risk of CHD in untreated individuals with familial hypercholesterolemia (FH) is more extreme when the disease is transmitted maternally. Methods: In a large Dutch pedigree carrying the V408M mutation in the low-density lipoprotein (LDL) receptor gene, 161 individuals over seven generations were identified for which FH status and parent of origin of FH were known. We calculated standardized mortality ratios (SMR) and compared the consequences of maternal and paternal inheritance of FH by Poisson regression analysis. Results: Maternally inherited FH was associated with significantly higher excess mortality than FH transmitted by fathers (relative risk 2.2; p = 0.048): the SMR of maternal inheritance was 2.49(95% confidence interval (CI) 1.45-3.99; p = 0.001), whereas it was not significantly increased in paternally inherited FH (SMR 1.30,95% CI 0.65-2.32; p = 0.234). Conclusion: Mortality rates are more increased when FH is inherited through the mother, supporting the fetal origin of adulthood disease hypothesis with all cause death, the most indisputable outcome measure. Future research should explore safe options for cholesterol-lowering therapy of pregnant women with FH in order to prevent unfavourable (epigenetic) consequences leading to atherosclerosis in their children. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:690 / 693
页数:4
相关论文
共 50 条
  • [41] Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia and Null Allele Low-Density Lipoprotein Receptor Mutations
    Vilades Medel, David
    Leta Petracca, Ruben
    Carreras Costa, Francesc
    Cardona Olle, Montserrat
    Barros Membrilla, Antonio
    Hidalgo Perez, Jose Alberto
    Pujadas Olano, Sandra
    Alomar Serrallach, Xavier
    Franco Peral, Miguel
    Pons-Llado, Guillem
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (07) : 955 - 961
  • [42] Heterozygous familial hypercholesterolemia in children: Low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations
    Torres, AL
    Moorjani, S
    Vohl, MC
    Gagne, C
    Lamarche, B
    Brun, LD
    Lupien, PJ
    Despres, JP
    ATHEROSCLEROSIS, 1996, 126 (01) : 163 - 171
  • [43] A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia
    Moffa, Simona
    Onori, Maria Elisabetta
    De Paolis, Elisa
    Tenore, Claudio Ricciardi
    Perrucci, Alessia
    Pontecorvi, Alfredo
    Giaccari, Andrea
    Urbani, Andrea
    Minucci, Angelo
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (02) : 1623 - 1630
  • [44] A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia
    Simona Moffa
    Maria Elisabetta Onori
    Elisa De Paolis
    Claudio Ricciardi Tenore
    Alessia Perrucci
    Alfredo Pontecorvi
    Andrea Giaccari
    Andrea Urbani
    Angelo Minucci
    Molecular Biology Reports, 2022, 49 : 1623 - 1630
  • [45] Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report
    Paththinige, C. S.
    Rajapakse, J. R. D. K.
    Constantine, G. R.
    Sem, K. P.
    Singaraja, R. R.
    Jayasekara, R. W.
    Dissanayake, V. H. W.
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [46] FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia
    Dedoussis, GVZ
    Pitsavos, C
    Kelberman, D
    Skoumas, J
    Prassa, ME
    Choumerianou, DM
    Stefanadis, C
    Humphries, SE
    Toutouzas, P
    CLINICAL GENETICS, 2003, 64 (05) : 414 - 419
  • [47] Analysis of low-density lipoprotein receptor gene mutations in a Chinese patient with clinically homozygous familial hypercholesterolemia
    Cao, SC
    Wang, LY
    Qin, YW
    Lin, J
    Wu, BJ
    Liu, S
    Pan, XD
    Du, LP
    Chen, BS
    CHINESE MEDICAL JOURNAL, 2003, 116 (10) : 1535 - 1538
  • [48] Identification of four novel mutations of the low-density lipoprotein receptor gene in Korean patients with familial hypercholesterolemia
    Shin, JA
    Kim, SH
    Kim, UK
    Chae, JJ
    Choe, SJ
    Namkoong, Y
    Kim, HS
    Park, YB
    Lee, CC
    CLINICAL GENETICS, 2000, 57 (03) : 225 - 229
  • [49] Low-density lipoprotein apheresis in familial hypercholesterolemia resistant to intensive medical treatment
    Arbona, Cristina
    Martinez-Hervas, Sergio
    Goterris, Rosa
    Montoro, Juan
    Tomas Real, Jose
    Francisco Ascaso, Juan
    MEDICINA CLINICA, 2013, 140 (05): : 207 - 210
  • [50] Efficacy of Low-Density Lipoprotein Cholesterol Apheresis in the Treatment of Familial Hypercholesterolemia: Single Center Experience
    Hacisahinogullari, Hulya
    Oyman, Gamze Bilik
    Mutlu, Ummu
    Dadin, Senem
    Yalin, Gulsah Y.
    Soyluk, Ozlem
    Gul, Nurdan
    Besisik, Sevgi Kalayoglu
    Satman, Ilhan
    Karsidag, Kubilay
    Uzum, Ayse Kubat
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2025, 133 (02) : 92 - 97